These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 324691)

  • 1. Cephalexin: clinical and laboratory evaluation in infants and children.
    Rudoy RC; Riley HD
    Clin Pediatr (Phila); 1977 Jul; 16(7):639-44. PubMed ID: 324691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Update on antibiotic therapy. 17) A combination of fosfomycin and cephalexin (cefemic cofosfolactamine)].
    Di Nola F
    Minerva Med; 1983 May; 74(20):1217-22. PubMed ID: 6379514
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of urinary tract infections in children and standards for evaluating its efficacy--with special reference to the therapeutic results of cephalexin suspensions].
    Kobayashi Y; Akaishi K; Nishio T; Goto K; Aihara M
    Jpn J Antibiot; 1972 Apr; 25(2):104-19. PubMed ID: 4561052
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bacteriological studies on cefatrizine (S-640 P) (author's transl)].
    Matsuzaki M; Tado N; Hirata Y; Kato M; Nakumura K
    Jpn J Antibiot; 1976 Jan; 29(1):61-8. PubMed ID: 4635
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory and clinical studies of cefaclor in Japan.
    Fujii R
    Postgrad Med J; 1979; 55 Suppl 4():88-92. PubMed ID: 398486
    [No Abstract]   [Full Text] [Related]  

  • 6. The Most Prevalent Organism in Diabetic Foot Ulcers and Its Drug Sensitivity and Resistance to Different Standard Antibiotics.
    Nageen A
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):293-6. PubMed ID: 27097700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative efficacy of cephalexin and sulfisoxazole in acute urinary tract infection in children.
    Russo RM; Gururaj VJ; Laude TA; Rajkumar SV; Allen JE
    Clin Pediatr (Phila); 1977 Jan; 16(1):83-4, 89-91. PubMed ID: 318609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Blood Culture Isolates and their Antibiogram in a Teaching hospital.
    Shrestha S; Amatya R; Shrestha RK; Shrestha R
    JNMA J Nepal Med Assoc; 2014; 52(193):692-6. PubMed ID: 26905550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laboratory and clinical studies of cefadroxil (author's transl)].
    Nishimura T; Kiromatsu K; Takashima T; Tabuki K; Kotani Y
    Jpn J Antibiot; 1981 Jan; 34(1):41-50. PubMed ID: 7017197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of cephalexin monohydrate in various bacterial infections].
    De La Cueva F; Ramirez Parra J
    Prensa Med Mex; 1970; ():23-6. PubMed ID: 4931112
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of Dosing of Cephalexin for Oral Step-Down Therapy of Pediatric Osteoarticular Infections Caused by Methicillin-Sensitive Staphylococcus Aureus.
    Ramchandar N; Arnold J; Cannavino C; Bradley JS
    Pediatr Infect Dis J; 2020 Jun; 39(6):523-525. PubMed ID: 32398570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
    Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of cephradine oral suspension in the treatment of bacterial infections of infants and children.
    Lipman RP; Silverman W
    Clin Pediatr (Phila); 1977 Sep; 16(9):835-7. PubMed ID: 330074
    [No Abstract]   [Full Text] [Related]  

  • 15. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
    Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basic and clinical examinations of CS-1170 in pediatrics (author's transl)].
    Nanri S; Sunakawa K; Hara N; Yamashita N; Akita H; Hotta M; Izeki M; Morikawa Y; Osano M; Ichihashi Y
    Jpn J Antibiot; 1979 Jan; 32(1):18-24. PubMed ID: 370423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of infections with parenteral cephalexin.
    Solberg CO; Schreiner A; Hamre E; Digranes A
    Chemotherapy; 1973 Oct; 19(4):215-20. PubMed ID: 4149295
    [No Abstract]   [Full Text] [Related]  

  • 18. Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections.
    Haynes AS; Wei Z; Anderson P; Scheetz MH; Parker SK; Fish DN
    Antimicrob Agents Chemother; 2024 May; 68(5):e0018224. PubMed ID: 38597672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-acyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acids. An improved synthesis and biological properties.
    Berges DA
    J Med Chem; 1975 Dec; 18(12):1264-5. PubMed ID: 811800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.